COMPANY

Ernexa Therapeutics

HQ: Cambridge, MA source · ernexatx.com ↗ · New England

Keywords: cell therapy oncology advanced cancer ovarian cancer

Location: Cambridge, MA · source · Sep 16, 2026

Profile checked Oct 10, 2026

Timeline

Feb 6, 2026 Raise Follow-on offering: $10.5M (total, as published), announced Feb 6, 2026. Source: SEC filing. source ↗
Apr 3, 2025 Raise Private placement: $5M (total, as published), announced Apr 3, 2025. Source: company release on GlobeNewswire. source ↗

Raised: $15.5M. Last 2 years.

Feb 6, 2026 Follow-on offering: $10.5M (total, as published), announced Feb 6, 2026. Source: SEC filing. source ↗
Apr 3, 2025 Private placement: $5M (total, as published), announced Apr 3, 2025. Source: company release on GlobeNewswire. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

2025-04-11 Raise Private raise (SEC Form D): $7.2M sold; issuer “Ernexa Therapeutics Inc.”. Verified from the SEC filing. SEC filing ↗
2024-11-14 Raise Private raise (SEC Form D): $3.9M sold; issuer “Eterna Therapeutics Inc.”. Verified from the SEC filing. SEC filing ↗
2024-11-14 Raise Private raise (SEC Form D): $1.1M sold; issuer “Eterna Therapeutics Inc.”. Verified from the SEC filing. SEC filing ↗